08Jun
FDA Signals a Deliberative Approach to Cannabis at Public Hearing
While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By:
Wilson Sonsini Goodrich & Rosati
Related
A Singaporean construction company in liquidation has successfully sued one of its former directors ...
Read More >
I once worked for a man who was the type of person who wouldn’t have minded to have lost $5 to save...
Read More >
Proposed regulations, if adopted, would impose substantial restrictions in many cases on a corporati...
Read More >
Illinois employers must begin preparing now for the host of new legal requirements impacting the wor...
Read More >
On February 26, 2020, the Supreme Court ruled in Intel Corp. Investment Policy Committee v. Sulyma, ...
Read More >
On February 20, 2020, the Ministry of Human Resources and Social Security, the Ministry of Finance, ...
Read More >